CRISPR/Cas9 Immune System as a Tool for Genome Engineering.
Level 5 - mechanism / opinion, no new human data
Narrative review of biological mechanisms and molecular biology tools with no primary clinical or experimental data reported in the abstract.
PubMed 27699445 · doi:10.1007/s00005-016-0427-5
What was done
This paper reviews the biological mechanism of the prokaryotic CRISPR/Cas adaptive immune system and describes how the CRISPR/Cas9 platform has been adapted for targeted genome engineering and transcriptional modulation.
What was found
The abstract provides a qualitative overview and reports no quantitative findings or numerical data. It notes that CRISPR/Cas9 enables modification of endogenous genes across various species and cell types, and that pairing modified Cas9 with transcriptional activators or repressors allows targeted regulation of gene expression.
Why it matters
It summarizes the principles and versatility of CRISPR/Cas9 as an accessible molecular tool for genetic modification and gene regulation across research, biotechnology, and biomedicine.
Limits
The abstract provides purely descriptive narrative claims without quantitative metrics, comparative efficacy data against other gene-editing tools, or experimental validation details.
Cited by
- supports CRISPR evolved naturally as a bacterial defense mechanism against bacteriophage viruses.